The Effects of Amiodarone on Thyroid Hormone Function: A Review of the Physiology and Clinical Manifestations
- 1 July 1990
- journal article
- review article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 30 (7) , 588-595
- https://doi.org/10.1002/j.1552-4604.1990.tb01861.x
Abstract
Amiodarone, an iodinated benzofuran derivative, is used for treatment of refractory cardiac arrhythmias. Certain features of the drug's structure resemble those of the biologically active thyroid hormone, triiodothyronine (T3). In addition, the drug has a variety of complex effects on thyroid hormone physiology, including a number of possible antagonistic effects on thyroid hormone function at the cellular level. The drug occasionally causes clinically overt hyperthyroidism and hypothyroidism. We review these effects and discuss their clinical implications.Keywords
This publication has 38 references indexed in Scilit:
- Antagonism of thyroid hormone action by amiodarone in rat pituitary tumor cells.Journal of Clinical Investigation, 1989
- Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexesThe American Journal of Cardiology, 1986
- Amiodarone, thyroid hormone indexes, and altered thyroid function: Long-term serial effects in patients with cardiac arrhythmiasThe American Journal of Cardiology, 1986
- Amiodarone Inhibits T4to T3Conversion and α-Glycerophosphate Dehydrogenase and Malic Enzyme Levels in Rat LiverHormone and Metabolic Research, 1986
- Effect of peripheral thyroid hormone metabolism on cardiac arrhythmiasThe American Journal of Cardiology, 1985
- Clinical Pharmacokinetics of AmiodaroneClinical Pharmacokinetics, 1984
- Amiodarone and thyroid function: Clinical implications during antiarrhythmic therapyAmerican Heart Journal, 1983
- Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy.Circulation, 1982
- Prednisone in amiodarone-induced thyrotoxicosis.BMJ, 1982
- Evidence for Two Tissue-specific Pathways for In Vivo Thyroxine 5′-Deiodination in the RatJournal of Clinical Investigation, 1982